Expanding bone cancer therapy radium-223 for other cancers

Radium-223 is highly effective for treating bone metastases in patients with castration-resistant prostate cancers. Despite the therapeutic potential of radium-223, its current formulation approved by the Food and Drug Administration is effective only for patients with bone metastases. Justin J.

Read the original article...